Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Feb 2026 for Swedish Orphan Biovitrum AB (publ), €72k.
Filing timeline
BuySaleIris Loew-Friedrich
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+7.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Iris Loew-Friedrich: trading record in brief
One trade, one date: on 10 February 2026, Iris Loew-Friedrich disclosed an open-market purchase of €72k in Swedish Orphan Biovitrum AB (publ). No broader history exists yet. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Iris Loew-Friedrich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 1,900 shares@ €38.09650.0005% mcap100.0% of flowAktieISIN SE0000872095FI:A003V827-1Canonical exit: 11 May 2026 (T+90)
1 of 1 declaration